March 6, 2018 / 1:31 PM / 8 months ago

BRIEF-AbbVie Gets Positive Recommendation From Pan-Canadian Oncology Drug Review For Venclexta

March 6 (Reuters) - AbbVie Inc:

* ABBVIE RECEIVES POSITIVE RECOMMENDATION FROM THE PAN-CANADIAN ONCOLOGY DRUG REVIEW FOR VENCLEXTA™ - AN ORAL THERAPY FOR THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

* ABBVIE CANADA - PCODR CONDITIONALLY RECOMMENDS REIMBURSEMENT OF VENCLEXTA FOR CLL PATIENTS WHO HAVE RECEIVED AT LEAST 1 PRIOR THERAPY & FAILED A BCRI​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below